Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation.
Lisa HertAlexandros A PolymerisSabine SchaedelinJohanna LiebDavid J SeiffgeChristopher TraenkaJoachim FladtSebastian ThilemannHenrik GensickeGian Marco De MarchisLeo BonatiPhilippe LyrerStefan T EngelterNils PetersPublished in: European stroke journal (2019)
In atrial fibrillation stroke patients treated with oral anticoagulation, small vessel disease is associated with an unfavourable outcome. The presence of microbleeds indicated a risk higher for recurrent ischaemic stroke than for intracranial haemorrhage.